Karyopharm Therapeutics Inc. (KPTI) Total assets 2016–2025
Karyopharm Therapeutics Inc. (KPTI) total assets at each fiscal year-end, per SEC filings.
$108.4MFY2025 · since FY2016: $180.4M → $108.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $108.4M | -34.1% |
| FY2024 | $164.4M | -31.6% |
| FY2023 | $240.4M | -32.9% |
| FY2022 | $358.2M | +17.3% |
| FY2021 | $305.3M | -2.5% |
| FY2020 | $313.1M | +6.1% |
| FY2019 | $295.0M | -13.5% |
| FY2018 | $341.2M | +89.2% |
| FY2017 | $180.3M | -0.1% |
| FY2016 | $180.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KPTI financial trends
KPTI RevenueKPTI Net incomeKPTI Net marginKPTI Gross profitKPTI Gross marginKPTI Operating incomeKPTI Operating marginKPTI Operating cash flowKPTI Free cash flowKPTI Capital expendituresKPTI Return on equityKPTI Stock buybacksKPTI Dividends paidKPTI Total liabilitiesKPTI Shareholders’ equityKPTI overview →